Avid Bioservices Inc (CDMO)

[purpledawgs]

PPHM needs to invest in someone who can actually infuse some enthusiasm into these presentations. It just seems like they downplay the data they have. Take for instance the remarks about the 85% response rate with the breast trial versus 40-50% expected with chemo alone. When King mumbles through it, that statment of almost 100% improvement in overall survival sounds like an afterthought that has no impact upon the audience. It seems all he did is read the slides. His presentation generated one question. Did people even understand all his terms and abbreviations? You have to sell the product to people and make them understand why they can't afford to pass up on PPHM and bavituximab. That was lacking. All IMO.

pd